Perritt Capital Management’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Perritt Capital Management’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200,000	Closed	-$99K	–	217
2019 Q4	$99K	Sell	200,000 -50,000	-20%	-$30.7K	0.05%	204
2019 Q3	$270K	Hold	250,000	–	–	0.11%	186
2019 Q2	$590K	Hold	250,000	–	–	0.23%	126
2019 Q1	$700K	Hold	250,000	–	–	0.26%	113
2018 Q4	$305K	Hold	250,000	–	–	0.12%	184
2018 Q3	$533K	Buy	+250,000	New	+$708K	0.16%	153

Other funds holding TMDI

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

COF

Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Perritt Capital Management's TMDI Position: Q1 2020 in Review

Perritt Capital Management sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2020, closing a stake of 200,000 shares — an estimated $99K sold.

Perritt Capital Management first reported a position in TMDI in Q3 2018 and held it in 6 quarters. The position peaked at $700K in Q1 2019. 39 funds tracked by Wall St. Rank hold TMDI as of Q1 2020.

Perritt Capital Management reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Perritt Capital Management sold 200,000 Titan Medical Inc. Ordinary Shares shares in Q1 2020, an estimated $99K.
Perritt Capital Management first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2018 and held it in 6 quarters.
Perritt Capital Management's Titan Medical Inc. Ordinary Shares position peaked at $700K in Q1 2019.
39 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2020.

Based on Perritt Capital Management's 13F filing for Q1 2020, filed 15 May 2020.